Some healthtech companies confuse visible activity with durable enterprise value, but buyers are underwriting something different.
There is a pattern that repeats across healthtech at every stage. A product drops, the pipeline fills, leadership calls it momentum. Then quietly, it fades. So, the team launches again. The cycle feels productive because there is visible output to point to. But none of it compounds. Launch-driven growth requires a fresh injection of effort every time, and the moment that stops, so does the growth. What leadership calls momentum, buyers call volatility. And in the current Mergers & Acquisitions (M&A) environment, that distinction is priced in.
Most healthtech companies don’t have a growth problem. They have a launch addiction. And it works…until it doesn’t.
Launch thinking is rewarding because it generates activity that is easy to see and easy to celebrate. A product announcement creates internal energy. A campaign creates movement. A press release signals that something is happening. The team has a shared goal, a deadline, and a result to point to.
That visibility is not nothing. Launches do drive awareness and move pipeline, at least in the short term. But the energy is borrowed. The moment the launch window closes, momentum must be rebuilt from scratch. No residue. No flywheel.
What makes this dangerous is that launch cycles mask structural gaps. The busyness of execution mode leaves little room to ask whether the underlying commercial model is working.
Sophisticated buyers are not impressed by launch history. They are stress-testing what comes after.
The questions in due diligence are direct:
These are not academic questions. Recent M&A analysis shows healthtech companies with recurring revenue and sustainable growth trajectories commanding significantly higher multiples than those that grew through event-driven spikes. Unprofitable firms dependent on launch cycles are trading at steep discounts or not closing at all.
Buyers are not underwriting your last launch. They are underwriting the system underneath it.
The transition from launch thinking to system thinking is not a tactical adjustment. It is a structural one. It requires building commercial infrastructure that generates demand without a triggering event.
That infrastructure has three layers:
In healthtech, where buying cycles span months and involve clinical, financial, and operational stakeholders, the absence of this infrastructure is immediately visible to anyone running serious diligence.
The compounding cost of launch dependency is rarely felt in the moment. It accumulates quietly, and by the time a company is trying to grow or sell at scale, the structural weaknesses are difficult to address quickly enough to matter.
Revenue becomes volatile because it is tied to campaign timing rather than a demand system. Pipeline becomes unpredictable because it only refills when effort is applied. The business grows over-reliant on conditions it cannot control: the right market moment, the right announcement cycle, the right window.
In the current M&A market, fragility shows up directly in valuation. Companies that cannot demonstrate demand independent of a launch event are being discounted or passed on entirely.
Every section of this points to the same question: when growth stops, does the business keep moving?
A launch-dependent company stalls the moment the campaign does. The pipeline dries up, the narrative shifts, and the team scrambles toward the next trigger. That pattern is immediately legible to anyone evaluating the business from the outside.
A system-driven company keeps generating. The demand engine runs. The ICP is clear. Revenue is predictable because it is not tied to a single event. That predictability is what buyers underwrite at a premium, and it is what separates a clean exit from a discounted one.
The healthtech companies that exit well built something underneath the launches that kept working when the noise faded.
Companies built on launches look exciting.
Companies built on systems get acquired.
Launch-driven growth means revenue depends on product announcements and campaigns rather than a self-sustaining commercial system. It feels productive but nothing compounds. Each cycle requires a fresh injection of effort, and when that stops, so does the growth. Buyers recognize this pattern as volatility, not traction.
Why does launch thinking feel productive even when it isn't building long-term value?
Launches generate visible, celebratory activity with shared goals and easy-to-point-to results. They do drive short-term pipeline movement. The danger is that the busyness masks structural gaps in the commercial model, keeping teams in execution mode without ever questioning whether the system actually works on its own.
What are buyers actually evaluating during M&A due diligence?
Buyers are stress-testing what happens after launch energy fades. They want to know if demand exists without a campaign, if the pipeline self-generates, and if the company maintains a consistent narrative across sales conversations. Companies with recurring, sustainable revenue command significantly higher multiples than those that grew through event-driven spikes.
What does a commercialization system look like, and what are its core components?
A commercialization system generates demand without needing a triggering event. It has three layers: an always-on demand engine that produces qualified opportunities independently; a clearly defined Ideal Customer Profile with real segmentation; and a consistent narrative across sales and marketing that does not shift based on who is in the room.
What are the long-term costs of staying in launch mode?
Revenue becomes volatile because it is tied to campaign timing rather than a demand system. Pipeline only refills when effort is actively applied. The business grows dependent on conditions it cannot control. By the time a company tries to grow or sell at scale, these structural weaknesses are difficult to fix quickly enough to matter.
How does building a system-driven company affect exit outcomes?
System-driven companies show predictable, self-sustaining revenue that buyers underwrite at a premium. Launch-dependent companies stall when campaigns stop, signaling fragility through a volatile pipeline and inconsistent narrative. In the current M&A market, that fragility shows up directly in valuation as discounts or passed deals.
It’s a practical conversation to determine whether the Enterprise Value Creation System™ fits your situation and what will most effectively strengthen your valuation.
No pitch. No pressure. Just clarity.